SOURCE: Ingen Technologies, Inc.

September 26, 2007 08:15 ET

Ingen Technologies, Inc. Announces the Exclusive Oxyview™ Distribution Deal With Invacare Supply Group, Inc.

YUCAIPA, CA--(Marketwire - September 26, 2007) - Ingen Technologies, Inc. (PINKSHEETS: IGTG), a medical device manufacturer, announced today that the Board of Directors approved the entry of Ingen into an exclusive distribution agreement with Invacare Supply Group, Inc. ("ISG"). ISG, a Massachusetts corporation, states that it has formalized a master distributor agreement with Ingen to exclusively distribute its innovative new oxygen flow meter, Oxyview™, for a term of up to 3 years. The territory includes North America, South America, Europe, Asia, Australia and New Zealand.

"We are very excited about the opportunity to distribute and help market Oxyview. This is very much in line with ISG's continuing efforts to bring innovation and high quality to its customers," says Doug Harper, General Manager of Invacare Supply Group.

Oxyview™ is the first oxygen flow meter that can validate flow rate nearest the patient or its destination where it matters the most. This device greatly differs from traditional flow meters in that it can be easily mounted "in-line" anywhere between the regulator and the patient in less than a minute and does not rely on gravity for its readings. With these special features, Oxyview™ is attractive to both patients and medical suppliers, whereas this safety device will prevent money spent on unnecessary customer service calls related to oxygen equipment usage, as well as provide peace of mind for the patient.

More than 8% of Americans suffer from various respiratory conditions and this problem translates into a large market for respiratory medical devices worldwide. As one of the major leaders in the respiratory care market, Ingen believes that ISG has proven to demonstrate the power and resources to market Oxyview™. The growth population of adults over 65 years of age in combination with better diagnosis in respiratory diseases, such as COPD, emphysema and bronchitis, along with increased life expectancy will help grow the non-asthma device market from $4B to over $6B by 2010.

Chris Wirth, COO of Ingen, states: "Oxyview™ will be a very strong competitor and participate in this growth because reliable oxygen therapy is critical to hundreds of millions of people worldwide. The company has made a major accomplishment in working with ISG as their sole exclusive distributor since ISG is already an established leading distributor of home health care products."

Thomas Neavitt, CFO of Ingen, adds: "ISG has a successful sales history and is focused in penetrating the respiratory and oxygen therapy markets with Oxyview™. With ISG's intentions to create respectable revenues through the sales and marketing of Oxyview™, this new business relationship has the potential to significantly increase earnings for Ingen Technologies over the next few years. We are pleased with ISG's expertise in opening the market for Oxyview; and our next new product, OxyAlert™ will already have an existing distribution market".

About Ingen Technologies, Inc.

Ingen Technologies, Inc., a Georgia Corporation, is a medical device manufacturer and a publicly traded company trading under (PINKSHEETS: IGTG), which has been in business since 1999. The primary mission of Ingen Technologies, Inc. is to provide innovative medical devices to the marketplace which enhance the practice of medicine by improving the diagnosis of and therapy for certain medical conditions, increase the number of patients to whom these health benefits become available, and reduce the cost of health care to society. A secondary mission is to assist in the commercialization of technologies which encourage production and consumption practices that promote the well-being of humans and their environment.

For more information, visit: www.ingen-tech.com

A Member of the Better Business Bureau

A Member of the Chamber of Commerce

A Licensed Business in the City of Yucaipa

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact Information

  • Contact:
    Scott R. Sand
    C.E.O & Chairman
    Ingen Technologies, Inc.
    Administrative Office
    35193 Avenue "A", Suite-C
    Yucaipa, California 92399
    Phone: (909) 790-7180
    Fax: (909) 795-6340
    Email: Email Contact